vs
AMERICAN SHARED HOSPITAL SERVICES（AMS）与Forian Inc.（FORA）财务数据对比。点击上方公司名可切换其他公司
Forian Inc.的季度营收约是AMERICAN SHARED HOSPITAL SERVICES的1.0倍（$8.0M vs $7.7M），AMERICAN SHARED HOSPITAL SERVICES净利率更高（-8.2% vs -22.9%，领先14.7%），Forian Inc.同比增速更快（37.0% vs -14.8%），过去两年Forian Inc.的营收复合增速更高（27.8% vs 21.7%）
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案，免除医院高昂的前期资本投入，主要业务覆盖北美，同时服务拉美及部分亚太地区的公立、私立医院客户。
Forian Inc是一家专注于医疗健康领域的数据分析与技术服务商，提供SaaS模式的真实世界证据解决方案、临床决策支持工具及运营优化服务，客户覆盖生物制药企业、医疗机构及生命科学领域相关机构，助力提升诊疗效率、推动医学研究进展。
AMS vs FORA — 直观对比
营收规模更大
FORA
是对方的1.0倍
$7.7M
营收增速更快
FORA
高出51.8%
-14.8%
净利率更高
AMS
高出14.7%
-22.9%
两年增速更快
FORA
近两年复合增速
21.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.7M | $8.0M |
| 净利润 | $-631.0K | $-1.8M |
| 毛利率 | 11.7% | 49.2% |
| 营业利润率 | -18.1% | -24.4% |
| 净利率 | -8.2% | -22.9% |
| 营收同比 | -14.8% | 37.0% |
| 净利润同比 | 52.5% | -1012.2% |
| 每股收益（稀释后） | $-0.09 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSFORA
| Q4 25 | $7.7M | $8.0M | ||
| Q3 25 | $7.2M | $7.8M | ||
| Q2 25 | $7.1M | $7.5M | ||
| Q1 25 | $6.1M | $7.1M | ||
| Q4 24 | $9.1M | $5.8M | ||
| Q3 24 | $7.0M | $4.7M | ||
| Q2 24 | $7.1M | $4.8M | ||
| Q1 24 | $5.2M | $4.9M |
净利润AMSFORA
| Q4 25 | $-631.0K | $-1.8M | ||
| Q3 25 | $-17.0K | $-151.2K | ||
| Q2 25 | $-280.0K | $224.8K | ||
| Q1 25 | $-625.0K | $-1.1M | ||
| Q4 24 | $-1.3M | $199.7K | ||
| Q3 24 | $-207.0K | $-204.9K | ||
| Q2 24 | $3.6M | $-2.6M | ||
| Q1 24 | $119.0K | $-1.2M |
毛利率AMSFORA
| Q4 25 | 11.7% | 49.2% | ||
| Q3 25 | 22.1% | 51.6% | ||
| Q2 25 | 23.1% | 56.8% | ||
| Q1 25 | 15.4% | 55.6% | ||
| Q4 24 | 35.3% | 58.3% | ||
| Q3 24 | 19.6% | 70.1% | ||
| Q2 24 | 35.0% | 62.2% | ||
| Q1 24 | 41.1% | 65.1% |
营业利润率AMSFORA
| Q4 25 | -18.1% | -24.4% | ||
| Q3 25 | -4.8% | -6.1% | ||
| Q2 25 | -7.7% | 0.6% | ||
| Q1 25 | -21.3% | -19.8% | ||
| Q4 24 | -20.2% | -24.9% | ||
| Q3 24 | -12.7% | -17.0% | ||
| Q2 24 | -0.0% | -62.2% | ||
| Q1 24 | -1.6% | -36.3% |
净利率AMSFORA
| Q4 25 | -8.2% | -22.9% | ||
| Q3 25 | -0.2% | -1.9% | ||
| Q2 25 | -4.0% | 3.0% | ||
| Q1 25 | -10.2% | -16.0% | ||
| Q4 24 | -14.6% | 3.4% | ||
| Q3 24 | -3.0% | -4.4% | ||
| Q2 24 | 51.0% | -53.4% | ||
| Q1 24 | 2.3% | -24.9% |
每股收益（稀释后）AMSFORA
| Q4 25 | $-0.09 | $-0.06 | ||
| Q3 25 | $0.00 | $0.00 | ||
| Q2 25 | $-0.04 | $0.01 | ||
| Q1 25 | $-0.10 | $-0.04 | ||
| Q4 24 | $-0.21 | $0.01 | ||
| Q3 24 | $-0.03 | $-0.01 | ||
| Q2 24 | $0.55 | $-0.08 | ||
| Q1 24 | $0.02 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | $31.6M |
| 总债务越低越好 | $17.4M | — |
| 股东权益账面价值 | $24.0M | $29.8M |
| 总资产 | $55.5M | $44.1M |
| 负债/权益比越低杠杆越低 | 0.72× | — |
8季度趋势，按日历期对齐
现金及短期投资AMSFORA
| Q4 25 | $3.5M | $31.6M | ||
| Q3 25 | $5.1M | $28.2M | ||
| Q2 25 | $11.1M | $35.6M | ||
| Q1 25 | $11.2M | $35.7M | ||
| Q4 24 | $11.0M | $35.1M | ||
| Q3 24 | $13.8M | $49.4M | ||
| Q2 24 | $14.2M | $48.0M | ||
| Q1 24 | $12.8M | $47.4M |
总债务AMSFORA
| Q4 25 | $17.4M | — | ||
| Q3 25 | $18.2M | — | ||
| Q2 25 | $19.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | $20.4M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $15.1M | — | ||
| Q1 24 | $15.6M | — |
股东权益AMSFORA
| Q4 25 | $24.0M | $29.8M | ||
| Q3 25 | $24.6M | $31.1M | ||
| Q2 25 | $24.5M | $30.9M | ||
| Q1 25 | $24.6M | $30.0M | ||
| Q4 24 | $25.2M | $30.1M | ||
| Q3 24 | $26.4M | $28.4M | ||
| Q2 24 | $26.5M | $27.2M | ||
| Q1 24 | $22.8M | $28.1M |
总资产AMSFORA
| Q4 25 | $55.5M | $44.1M | ||
| Q3 25 | $59.6M | $41.3M | ||
| Q2 25 | $63.5M | $48.5M | ||
| Q1 25 | $63.3M | $48.6M | ||
| Q4 24 | $60.2M | $47.2M | ||
| Q3 24 | $63.3M | $57.5M | ||
| Q2 24 | $60.8M | $58.4M | ||
| Q1 24 | $50.1M | $57.5M |
负债/权益比AMSFORA
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 0.81× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-704.0K | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-2.7M | — |
| 自由现金流率自由现金流/营收 | -34.8% | — |
| 资本支出强度资本支出/营收 | 25.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.5M | — |
8季度趋势，按日历期对齐
经营现金流AMSFORA
| Q4 25 | $-704.0K | $3.2M | ||
| Q3 25 | $1.7M | $-439.7K | ||
| Q2 25 | $-372.0K | $-344.5K | ||
| Q1 25 | $2.5M | $448.2K | ||
| Q4 24 | $274.0K | $1.7M | ||
| Q3 24 | $472.0K | $764.1K | ||
| Q2 24 | $1.3M | $-23.1K | ||
| Q1 24 | $-1.9M | $-2.2M |
自由现金流AMSFORA
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-1.5M | — | ||
| Q4 24 | $-4.4M | — | ||
| Q3 24 | $-407.0K | — | ||
| Q2 24 | $70.0K | — | ||
| Q1 24 | $-3.0M | — |
自由现金流率AMSFORA
| Q4 25 | -34.8% | — | ||
| Q3 25 | -28.3% | — | ||
| Q2 25 | -32.1% | — | ||
| Q1 25 | -24.7% | — | ||
| Q4 24 | -48.4% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | -58.4% | — |
资本支出强度AMSFORA
| Q4 25 | 25.7% | — | ||
| Q3 25 | 51.6% | — | ||
| Q2 25 | 26.9% | — | ||
| Q1 25 | 65.7% | — | ||
| Q4 24 | 51.4% | 0.0% | ||
| Q3 24 | 12.6% | 0.0% | ||
| Q2 24 | 17.2% | 0.0% | ||
| Q1 24 | 22.7% | 0.0% |
现金转化率AMSFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.53× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 8.76× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | -15.67× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
FORA
| Financial Services Revenues | $7.3M | 92% |
| Other | $669.0K | 8% |
